2004•European NeuropsychopharmacologyRequires access

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

Smulevich Ab, Sumant Khanna, Mariëlle Eerdekens, Keith Karcher, Michelle Kramer, Fred Grossman

Open publisher page 193 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 193 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Risperidone, Haloperidol, Young Mania Rating Scale, Mania, Placebo, Psychology, Antipsychotic, Extrapyramidal symptoms

Back to paper search Browse research topics Original source

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol — Research Paper | ScholarLens